European regulators approve Humira for psoriasis

12/20/2007 | Forbes · Reuters

Abbott Laboratories has obtained European Commission approval to market its injectable rheumatoid arthritis drug, Humira, as a treatment for moderate to severe psoriasis. The drug was effective in clearing 75% or more of inflamed red skin lesions in more than three-fourths of patients during a clinical trial, according to Abbott.

View Full Article in:

Forbes · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC